Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-26

Clinical Trial Update: Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty [NA]

View source ↗

Summary

This clinical trial compares epsilon-aminocaproic acid, tranexamic acid, and placebo for preventing blood loss in total knee arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epsilon-aminocaproic acid (epsilon-aminocaproic acid)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Heekin Orthopedic Research Institute | Conditions: Osteoarthritis | NA | Status: UNKNOWN